GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dynavax Technologies Corp (NAS:DVAX) » Definitions » E10

DVAX (Dynavax Technologies) E10 : $-1.53 (As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Dynavax Technologies E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Dynavax Technologies's adjusted earnings per share data for the three months ended in Dec. 2024 was $0.050. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1.53 for the trailing ten years ended in Dec. 2024.

During the past 3 years, the average E10 Growth Rate was 19.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Dynavax Technologies was 28.40% per year. The lowest was 11.30% per year. And the median was 15.30% per year.

As of today (2025-03-03), Dynavax Technologies's current stock price is $13.80. Dynavax Technologies's E10 for the quarter that ended in Dec. 2024 was $-1.53. Dynavax Technologies's Shiller PE Ratio of today is .


Dynavax Technologies E10 Historical Data

The historical data trend for Dynavax Technologies's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dynavax Technologies E10 Chart

Dynavax Technologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.17 -2.88 -2.34 - -1.53

Dynavax Technologies Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -1.94 -1.81 -1.66 -1.53

Competitive Comparison of Dynavax Technologies's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Dynavax Technologies's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dynavax Technologies's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dynavax Technologies's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Dynavax Technologies's Shiller PE Ratio falls into.



Dynavax Technologies E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dynavax Technologies's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.05/133.1571*133.1571
=0.050

Current CPI (Dec. 2024) = 133.1571.

Dynavax Technologies Quarterly Data

per share eps CPI Adj_EPS
201503 -0.970 99.621 -1.297
201506 -0.800 100.684 -1.058
201509 -0.820 100.392 -1.088
201512 -0.700 99.792 -0.934
201603 -0.700 100.470 -0.928
201606 -0.750 101.688 -0.982
201609 -0.900 101.861 -1.177
201612 -0.560 101.863 -0.732
201703 -0.600 102.862 -0.777
201706 -0.410 103.349 -0.528
201709 -0.380 104.136 -0.486
201712 -0.450 104.011 -0.576
201803 -0.630 105.290 -0.797
201806 -0.630 106.317 -0.789
201809 -0.650 106.507 -0.813
201812 -0.640 105.998 -0.804
201903 -0.620 107.251 -0.770
201906 -0.660 108.070 -0.813
201909 -0.490 108.329 -0.602
201912 -0.440 108.420 -0.540
202003 -0.250 108.902 -0.306
202006 -0.530 108.767 -0.649
202009 0.040 109.815 0.049
202012 -0.140 109.897 -0.170
202103 0.010 111.754 0.012
202106 0.020 114.631 0.023
202109 -0.240 115.734 -0.276
202112 0.550 117.630 0.623
202203 0.220 121.301 0.242
202206 0.870 125.017 0.927
202209 0.430 125.227 0.457
202212 0.450 125.222 0.479
202303 -0.190 127.348 -0.199
202306 0.030 128.729 0.031
202309 0.100 129.860 0.103
202312 0.000 129.419 0.000
202403 -0.070 131.776 -0.071
202406 0.080 132.554 0.080
202409 0.120 133.029 0.120
202412 0.050 133.157 0.050

Add all the adjusted EPS together and divide 10 will get our e10.


Dynavax Technologies  (NAS:DVAX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Dynavax Technologies E10 Related Terms

Thank you for viewing the detailed overview of Dynavax Technologies's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Dynavax Technologies Business Description

Traded in Other Exchanges
Address
2100 Powell Street, Suite 720, Emeryville, CA, USA, 94608
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
Executives
Francis Cano director 11 ACORN LANE, LOS ALTOS CA 94022
Justin Burgess officer: Principal Accounting Officer C/O DYNAVAX TECHNOLOGIES CORPORATION, 2100 POWELL STREET, SUITE 1900, EMERYVILLE CA 94608
Robert Janssen officer: Chief Medical Officer and VP C/O DYNAVAX TECHNOLOGIES, 2929 SEVENTH STREET, SUITE 100, BERKELEY CA 94710
David F Novack officer: Senior Vice President 39 YORKSHIRE DR, OAKLAND CA 94618
Hack Andrew A. F. director 300 THIRD STREET, FIRST FLOOR, CAMBRIDGE MA 02142
Ryan Spencer officer: Co-President and Senior VP C/O DYNAVAX TECHNOLOGIES CORPORATION, 2929 SEVENTH STREET, SUITE 100, BERKELEY CA 94710-2753
Elaine D Sun director 11388 SORRENTO VALLEY ROAD, SAN DIEGO CA 92121
Scott Dunseth Myers director C/O CASCADIAN THERAPEUTICS, INC., 3101 WESTERN AVE., SUITE 600, SEATTLE WA 98121
Kelly Macdonald officer: SVP and CFO 100 SUMMER STREET, SUITE 2300, BOSTON MA 02110
Peter R. Paradiso director C/O DYNAVAX TECHNOLOGIES CORPORATION, 2100 POWELL STREET, SUITE 900, EMERYVILLE CA 94608
Julia Marie Eastland director C/O CASCADIAN THERAPEUTICS, INC., 3101 WESTERN AVE., SUITE 600, SEATTLE WA 98121
Brent Macgregor director C/O DYNAVAX TECHNOLOGIES CORPORATION, 2100 POWELL STREET, SUITE 900, EMERYVILLE CA 94608
Peggy V Phillips director C/O DYNAVAX TECHNOLOGIES CORPORATION, 2929 SEVENTH STREET, SUITE 100, BERKELEY CA 94710
Robert Coffman officer: Chief Science Officer and VP C/O DYNAVAX TECHNOLOGIES CORP, 2929 SEVENTH ST STE 100, BERKELEY CA 94710
Michael S Ostrach officer: VP, CBO, and General Counsel 1300 SEAPORT BOULEVARD, REDWOOD CITY CA 94063